A total of 22 of 45 carriers (48.9%) of an FH variant met clinical criteria for severe hypercholesterolemia (estimated untreated LDL cholesterol ≥190 mg/dL) compared with 951 of 9648 noncarriers (9.9%) (Figure 1B). The gene discussed is FH; the disease is Hypercholesterolemia.